Drug trial results refine treatment during angioplasty operations
Tuesday, August 31, 2010 - 05:21
in Health & Medicine
A landmark international study, coordinated by McMaster University, has found that lower doses of a blood thinner called unfractionated heparin (UFH) during angioplasty did not reduce bleeding or vascular complications compared to standard dose UFH in patients initially treated with a blood thinner, fondaparinux.